sertraline has been researched along with Acute Coronary Syndrome in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
García Diaz, B; Hidalgo Correas, FJ; Rubio Álvaro, N; Tejedor Prado, P | 1 |
Bigger, JT; Gaffney, M; Glassman, AH | 1 |
Steptoe, A; Williams, ED | 1 |
Cherubini, A; Di Bari, M; Furneri, G; Lattanzio, F; Marchionni, N | 1 |
1 review(s) available for sertraline and Acute Coronary Syndrome
Article | Year |
---|---|
The role of depression in the etiology of acute coronary syndrome.
Topics: Acute Coronary Syndrome; Depression; Heart Rate; Humans; Prevalence; Selective Serotonin Reuptake Inhibitors; Sertraline | 2007 |
3 other study(ies) available for sertraline and Acute Coronary Syndrome
Article | Year |
---|---|
[Serious QT interval prolongation associated with velafaxine administration].
Topics: Acute Coronary Syndrome; Adult; Antidepressive Agents; Cardiovascular Agents; Diagnostic Errors; Drug Substitution; Electrocardiography; Humans; Long QT Syndrome; Male; Sertraline; Sodium Channel Blockers; Tachycardia, Sinus; Venlafaxine Hydrochloride | 2014 |
Psychiatric characteristics associated with long-term mortality among 361 patients having an acute coronary syndrome and major depression: seven-year follow-up of SADHART participants.
Topics: Acute Coronary Syndrome; Depressive Disorder, Major; Female; Follow-Up Studies; Guideline Adherence; Hospitalization; Humans; Longitudinal Studies; Male; Medication Adherence; Middle Aged; Proportional Hazards Models; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Recurrence; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index | 2009 |
Sertraline treatment for depression associated with acute coronary syndromes: a cost analysis from the viewpoint of the Italian Healthcare System.
Topics: Acute Coronary Syndrome; Aged; Antidepressive Agents; Cost-Benefit Analysis; Costs and Cost Analysis; Delivery of Health Care; Depression; Diagnosis-Related Groups; Economics, Pharmaceutical; Humans; Italy; Middle Aged; Sertraline | 2008 |